Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma

BACKGROUND: A doxorubicin (DOX)-based chemotherapy protocol, CHOP, is the most effective treatment for canine high-grade B-cell lymphoma; however, the cost and time requirements associated with this protocol are not feasible for many pet owners. An alternative treatment option is the use of DOX, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Nadaf, Sami, Rebhun, Robert B., Curran, Kaitlin M., Venable, Rachel O., Skorupski, Katherine A., Willcox, Jennifer L., Burton, Jenna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245930/
https://www.ncbi.nlm.nih.gov/pubmed/30458771
http://dx.doi.org/10.1186/s12917-018-1688-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245930/
https://www.ncbi.nlm.nih.gov/pubmed/30458771
http://dx.doi.org/10.1186/s12917-018-1688-5

Ejemplares similares